DEA Faces Second Lawsuit From More Medical Marijuana Businesses That Say Rescheduling Rules Could Upend State Markets

The Quick Take
A second group of medical cannabis businesses are suing the Drug Enforcement Administration (DEA) over restrictions the agency is placing on marijuana businesses in conjunction with the Trump administration’s federal rescheduling move that industry observers and regulators believe could upend state-licensed markets. The latest challenge comes from four vertically integrated medical cannabis…
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Marijuana Moment.
Related
Business
American Airlines announces COO retirement and names JonCarlo Gulbranson as successor
Business
Nextpower Inc stock hits 52-week low at 74.24 USD
Business
US Treasury presses Singapore and Malaysia on Iran sanctions compliance
Business
Frost & Sullivan Forecasts Global Cloud Security Market to Reach $26.8 Billion by 2031 as AI and Unified Security Platforms Drive Growth
New research highlights how runtime protection, AI security and managed services are transforming cloud security, creating significant opportunities for…
